Skip to content
Register

BiotechPharmaChance

pharmatrader

Last Login: 03/20/2020


Overview
News
Trading idea
Portfolio
Key figures
Trades
blank

You want access to all the information?

To see the current portfolio of this wikifolio, the wikifolio chart, all key figures and previous trades, register now - completely free of charge.

RegisterLogin
-4.1%
since 5/13/2018

-0.7%
Ø-Perf. per year

-1.0%
Performance (1yr)

0.0%
Volatility (1yr)

-0.1
Return/Risk



Portfolio chart

Details

Tags

Feed

Trading Idea

Gehandelt werden Biotech oder Pharmafirmen, die durch ihre aktuelle Pipeline Chancen bieten oder an der Schwelle stehen profitabel zu werden. Ich beschränke mich ausschließlich auf Aktien. Wichtig sind mir nicht nur marktreife Produkte, sondern auch eine Chance im Pharmamarkt Geld zu verdienen.

This content is not available in the current language.

Master data

Symbol

WFBIOCHANC

Date created

05/13/2018

Index level

-

High watermark

96.1

Investment Universe

blank

You want access to all the information?

To see the current portfolio of this wikifolio, the wikifolio chart, all key figures and previous trades, register now - completely free of charge.

For the composition of the virtual portfolio click here.

More top wikifolios

Trend & Fundamental

Kai Knobloch

+10.9%
Ø-Perf. per year

Szew Grundinvestment

Simon Weishar

+23.2%
Ø-Perf. per year

Tech & GreenTech Aktienwerte

Vincent Soltau

+18.7%
Ø-Perf. per year

Artificial Intelligence

Thomas Schuster

+17.4%
Ø-Perf. per year

Top Hedge

Ralph Markus Sonderhüsken

+15.9%
Ø-Perf. per year

Typ Distressed Value

André Luger

+16.7%
Ø-Perf. per year

PRIVALOR AG Aktienstrategie IX

Peter Kugel

+5.7%
Ø-Perf. per year

World's Best Brands

Yves Lienhard

+11.1%
Ø-Perf. per year

Cybersecurity Innovators

Dirk Althaus

+19.7%
Ø-Perf. per year
Discover
  • Current wikifolios
  • Investment trends
  • wikifolio traders

+49 (0) 211 247 907 70service@wikifolio.com
GTCImprintData protectionCookie declaration
2024 © wikifolio Financial Technologies AG